Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akihiro Katayama

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 20, 2011
[Chronic kidney disease]Akihiro Katayama, Jun Wada, Hirofumi Makino
Journal of Diabetes Research|December 21, 2016
Risk Factors for the Requirement of Antenatal Insulin Treatment in Gestational Diabetes MellitusMayu Watanabe, Akihiro Katayama, Hidetoshi Kagawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinomaAkihiro Katayama, Takeshi Ogino, Nobuyuki Bandoh, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 2, 2002
[Evaluation of preoperative simultaneous radiochemotherapy combined with carboplatin and tegafur.uracil]Akihiro Katayama, Satoshi Nonaka, Nobuyuki Bandoh, et al.
Cancer Research|September 20, 2006
HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic markerTakeshi Ogino, Hiroshi Shigyo, Hideyuki Ishii, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosisAkihiro Katayama, Nobuyuki Bandoh, Kan Kishibe, et al.
Journal of Diabetes Investigation|April 8, 2025
Case of type 1 diabetes mellitus with decreased hemoglobin glycation index after switching insulin pumpMomoka Hasegawa, Akihiro Katayama, Eisaku Morimoto, et al.
International Journal of Oncology|August 3, 2007
Overexpression of small ubiquitin-related modifier-1 and sumoylated Mdm2 in oral squamous cell carcinoma: possible involvement in tumor proliferation and prognosisAkihiro Katayama, Takeshi Ogino, Nobuyuki Bandoh, et al.
Oncology Reports|March 6, 2010
HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosisNobuyuki Bandoh, Takeshi Ogino, Akihiro Katayama, et al.
Scientific Reports|September 15, 2021
Author Correction: Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2Tomokazu Nunoue, Satoshi Yamaguchi, Sanae Teshigawara, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 20, 2011
[Chronic kidney disease]Akihiro Katayama, Jun Wada, Hirofumi Makino
Journal of Diabetes Research|December 21, 2016
Risk Factors for the Requirement of Antenatal Insulin Treatment in Gestational Diabetes MellitusMayu Watanabe, Akihiro Katayama, Hidetoshi Kagawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinomaAkihiro Katayama, Takeshi Ogino, Nobuyuki Bandoh, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 2, 2002
[Evaluation of preoperative simultaneous radiochemotherapy combined with carboplatin and tegafur.uracil]Akihiro Katayama, Satoshi Nonaka, Nobuyuki Bandoh, et al.
Cancer Research|September 20, 2006
HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic markerTakeshi Ogino, Hiroshi Shigyo, Hideyuki Ishii, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosisAkihiro Katayama, Nobuyuki Bandoh, Kan Kishibe, et al.
Journal of Diabetes Investigation|April 8, 2025
Case of type 1 diabetes mellitus with decreased hemoglobin glycation index after switching insulin pumpMomoka Hasegawa, Akihiro Katayama, Eisaku Morimoto, et al.
International Journal of Oncology|August 3, 2007
Overexpression of small ubiquitin-related modifier-1 and sumoylated Mdm2 in oral squamous cell carcinoma: possible involvement in tumor proliferation and prognosisAkihiro Katayama, Takeshi Ogino, Nobuyuki Bandoh, et al.
Oncology Reports|March 6, 2010
HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosisNobuyuki Bandoh, Takeshi Ogino, Akihiro Katayama, et al.
Scientific Reports|September 15, 2021
Author Correction: Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2Tomokazu Nunoue, Satoshi Yamaguchi, Sanae Teshigawara, et al.
Pageof 7